Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference
February 23 2021 - 07:30AM
Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a
dermatology therapeutics company developing medications for skin
diseases requiring medical interventions, today announced that Ted
White, Verrica President and CEO, will present a business overview
at the Cowen 41st Annual Health Care Conference on Tuesday, March
2, 2021, at 11:50 a.m. ET.
Participants may access a live webcast of the
event through the following
link: https://wsw.com/webcast/cowen81/vrca/1949628.
The webcast can also be accessed in the
Investors/Presentations & Events section of the Verrica website
at www.verrica.com. The webcast replay will be available shortly
after conclusion of the event for 30 days.
About Verrica Pharmaceuticals
Inc.
Verrica is a dermatology therapeutics company
developing medications for skin diseases requiring medical
interventions. Verrica’s late-stage product candidate, VP-102, is
in development to treat molluscum contagiosum (molluscum), common
warts and external genital warts, three of the largest unmet needs
in medical dermatology. Verrica is also developing VP-103, its
second cantharidin-based product candidate, for the treatment of
plantar warts. The Company has also entered a worldwide license
agreement with Lytix Biopharma AS to develop and commercialize
LTX-315 for dermatologic oncology conditions. For more information,
Visit www.verrica.com.
FOR MORE INFORMATION, PLEASE
CONTACT:
Investors:
A. Brian DavisChief Financial
Officer484.453.3300 ext. 103info@verrica.com
William WindhamSolebury
Trout646.378.2946wwindham@troutgroup.com
Media:
Zara LockshinSolebury
Trout646.378.2960zlockshin@troutgroup.com
Verrica Parmaceuticals (NASDAQ:VRCA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Verrica Parmaceuticals (NASDAQ:VRCA)
Historical Stock Chart
From Mar 2023 to Mar 2024